Swiss pharmaceuticals maker Novartis says net income from continued operations fell 13 percent in the first quarter as generic competition cut into sales of Gleevec, one of the first very effective cancer medicines.
Apr 21, 2016
0
1
Neuroscientists at EPFL identify a brain region that links anxious temperament to low social status. The researchers were able to tweak social hierarchy in animals by using vitamin B3.
Dec 1, 2015
1
192
The vital ecosystem of bacteria in the human gut operates like a jungle, with competition between microbes helping maintain the stability necessary to keep us healthy.
Nov 5, 2015
0
244
Swiss pharmaceutical giant Novartis says net income fell 42 percent in the third quarter, largely due to the sale of its hepatitis drug unit a year earlier and provisions for legal settlements and fees.
Oct 27, 2015
0
4
The Food and Drug Administration released its proposal Thursday for naming lower-cost biotech drugs, a critical step in creating a market for the new class of medicines.
Aug 27, 2015
0
5
The soft signs of compulsive gambling—high energy levels, unreasonable expectations, extreme competitiveness, distorted optimism and above-average IQs—are often the very traits that characterize competing athletes. However, ...
May 11, 2015
0
14
Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...
Apr 28, 2015
0
3
Federal health officials have approved the first lower-cost copy of a biotech drug to reach the U.S. market, a long-awaited milestone that could generate billions in savings for insurers, doctors and patients.
Mar 6, 2015
0
9
(AP)—The Supreme Court ruled Wednesday that a state regulatory board made up mostly of dentists violated federal law against unfair competition when it tried to prevent lower-cost competitors in other fields from offering ...
Feb 25, 2015
1
4
According to the Centers for Disease Control and Prevention, two million people become infected with antibiotic resistant bacteria each year, leading to at least 23,000 deaths. And these infections cost a lot – US$20billion ...
Feb 9, 2015
0
8
